Production (Stage)
Dexterra Group Inc.
HZNOF
$6.12
-$0.02-0.33%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 727.15M | 732.12M | 725.06M | 725.48M | 699.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 727.15M | 732.12M | 725.06M | 725.48M | 699.96M |
| Cost of Revenue | 605.13M | 614.95M | 611.63M | 611.59M | 592.00M |
| Gross Profit | 122.02M | 117.17M | 113.43M | 113.89M | 107.96M |
| SG&A Expenses | 45.03M | 42.55M | 39.76M | 36.64M | 34.35M |
| Depreciation & Amortization | 26.34M | 25.68M | 25.19M | 25.93M | 26.06M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 676.50M | 683.18M | 676.58M | 674.16M | 652.41M |
| Operating Income | 50.65M | 48.94M | 48.48M | 51.33M | 47.56M |
| Income Before Tax | 42.49M | 39.09M | 37.75M | 38.73M | 35.42M |
| Income Tax Expenses | 12.38M | 11.70M | 9.68M | 10.09M | 9.02M |
| Earnings from Continuing Operations | 30.11 | 27.39 | 28.07 | 28.64 | 26.40 |
| Earnings from Discontinued Operations | -6.90M | -12.84M | -18.68M | -14.52M | -12.60M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -164.30K | -162.30K | -121.10K | -119.60K | -73.40K |
| Net Income | 23.04M | 14.39M | 9.27M | 13.99M | 13.73M |
| EBIT | 50.65M | 48.94M | 48.48M | 51.33M | 47.56M |
| EBITDA | 75.61M | 74.62M | 73.67M | 77.26M | 73.61M |
| EPS Basic | 0.36 | 0.23 | 0.14 | 0.22 | 0.21 |
| Normalized Basic EPS | 0.41 | 0.38 | 0.37 | 0.40 | 0.37 |
| EPS Diluted | 0.36 | 0.23 | 0.14 | 0.21 | 0.21 |
| Normalized Diluted EPS | 0.41 | 0.38 | 0.37 | 0.40 | 0.37 |
| Average Basic Shares Outstanding | 254.67M | 256.07M | 256.97M | 257.91M | 259.00M |
| Average Diluted Shares Outstanding | 256.35M | 257.22M | 257.70M | 258.60M | 259.70M |
| Dividend Per Share | 0.25 | 0.26 | 0.26 | 0.26 | 0.26 |
| Payout Ratio | 69.73% | 113.90% | 178.63% | 119.31% | 122.70% |